TitleNovel oral detoxification of mercury, cadmium, and lead with thiol-modified nanoporous silica.
Publication TypeJournal Article
Year of Publication2014
AuthorsSangvanich, T, Morry, J, Fox, C, Ngamcherdtrakul, W, Goodyear, S, Castro, D, Fryxell, GE, Addleman, RS, Summers, AO, Yantasee, W
JournalACS Appl Mater Interfaces
Volume6
Issue8
Pagination5483-93
Date Published2014 Apr 23
ISSN1944-8252
Abstract

We have developed a thiol-modified nanoporous silica material (SH-SAMMS) as an oral therapy for the prevention and treatment of heavy metal poisoning. SH-SAMMS has been reported to be highly efficient at capturing heavy metals in biological fluids and water. Herein, SH-SAMMS was examined for efficacy and safety in both in vitro and in vivo animal models for the oral detoxification of heavy metals. In simulated gastrointestinal fluids, SH-SAMMS had a very high affinity (Kd) for methyl mercury (MeHg(I)), inorganic mercury (Hg(II)), lead (Pb(II)), and cadmium (Cd(II)) and was superior to other SAMMS with carboxylic acid or phosphonic acid ligands or commercially available metal chelating sorbents. SH-SAMMS also effectively removed Hg from biologically digested fish tissue with no effect on most nutritional minerals found in fish. SH-SAMMS could hold Hg(II) and MeHg(I) tightly inside the nanosize pores, thus preventing bacteria from converting them to more absorbable forms. Rats fed a diet containing MeHg(I), Cd(II), and Pb(II) and SH-SAMMS for 2 weeks had blood Hg levels significantly lower than rats fed the metal-rich diet only. Upon cessation of the metal-rich diet, continued administration of SH-SAMMS for 2 weeks facilitated faster and more extensive clearance of Hg than in animals not continued on oral SH-SAMMS. Rats receiving SH-SAMMS also suffered less weight loss as a result of the metal exposure. Retention of Hg and Cd in major organs was lowest in rats fed with SH-SAMMS throughout the entire four weeks. The reduction of blood Pb by SH-SAMMS was significant. SH-SAMMS was safe to intestinal epithelium model (Caco-2) and common intestinal bacteria (Escherichia coli). Altogether, it has great potential as a new oral drug for the treatment of heavy metal poisoning. This new application is enabled by the installation of tailored interfacial chemistry upon nontoxic nanoporous materials.

DOI10.1021/am5007707
Alternate JournalACS Appl Mater Interfaces
PubMed ID24660651
PubMed Central IDPMC4004256
Grant ListR01GM089918 / GM / NIGMS NIH HHS / United States
R21ES015620 / ES / NIEHS NIH HHS / United States
R41DK094571 / DK / NIDDK NIH HHS / United States
Department Authors: 
Anne O. Summers